Glaukos Corporation (GKOS) Tops Q4 EPS by 17c, Offers FY Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. XYZ
9. SPY
10. FISV

Go back to Glaukos Corporation (GKOS) Tops Q4 EPS by 17c, Offers FY Guidance

Glaukos Corporation Announces Fourth Quarter and Full Year 2018 Financial Results

February 27, 2019 4:10 PM EST

SAN CLEMENTE, Calif.--(BUSINESS WIRE)-- Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to transform the treatment of glaucoma, today announced financial results for the fourth quarter and full year ended December 31, 2018. Key highlights include:

Achieved 30% net sales growth to $54.1 million in the fourth quarter of 2018, compared to $41.7 million in the fourth quarter of 2017. Reported 14% growth in net sales to $181.3 million for 2018, compared to $159.3 million in 2017.... More